Aspirin
2019XK320061
Approved small_molecule active
Quick answer
Aspirin for Acute Coronary Syndrome is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Coronary Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active